Arlington Partners’s Encompass Health EHC Stock Holding History

Arlington Partners’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-396,889	Closed	-$26.5M	–	112
2023 Q4	$26.5M	Buy	+396,889	New	+$25.7M	7.61%	3
2023 Q3	–	Sell	-315	Closed	-$21.3K	–	470
2023 Q2	$21.3K	Hold	315	–	–	﹤0.01%	386
2023 Q1	$17K	Hold	315	–	–	﹤0.01%	368
2022 Q4	$18.8K	Hold	315	–	–	﹤0.01%	312
2022 Q3	$14K	Sell	315 -81	-20%	-$4.05K	0.01%	287
2022 Q2	$18K	Hold	396	–	–	0.01%	334
2022 Q1	$22K	Sell	396 -1,376	-78%	-$71.8K	0.01%	319
2021 Q4	$92K	Hold	1,772	–	–	0.02%	211
2021 Q3	$106K	Hold	1,772	–	–	0.03%	166
2021 Q2	$110K	Buy	1,772 +105	+6%	+$7K	0.04%	127
2021 Q1	$109K	Buy	+1,667	New	+$109K	0.04%	141
2019 Q3	–	Sell	-290	Closed	-$15K	–	188
2019 Q2	$15K	Buy	+290	New	+$14.1K	0.01%	185
2018 Q4	–	Sell	-251	Closed	-$16K	–	226
2018 Q3	$16K	Buy	+251	New	+$15.3K	0.01%	183

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arlington Partners's EHC Position: Q1 2024 in Review

Arlington Partners sold out of Encompass Health (EHC) in Q1 2024, closing a stake of 396,889 shares — an estimated $26.5M sold.

Arlington Partners first reported a position in EHC in Q3 2018 and held it in 13 quarters. The position peaked at $26.5M in Q4 2023. 437 funds tracked by Wall St. Rank hold EHC as of Q1 2024.

Arlington Partners reported no remaining Encompass Health position as of Q1 2024 after selling out during the quarter.
Arlington Partners sold 396,889 Encompass Health shares in Q1 2024, an estimated $26.5M.
Arlington Partners first reported a position in Encompass Health in Q3 2018 and held it in 13 quarters.
Arlington Partners's Encompass Health position peaked at $26.5M in Q4 2023.
437 funds tracked by Wall St. Rank held Encompass Health as of Q1 2024.

Based on Arlington Partners's 13F filing for Q1 2024, filed 16 Apr 2024.